Medicare Steering Committee letter discusses issues related to eligibility and enrollment, benefits and beneficiary protections, submission of bids and monthly beneficiary premiums, payments to prescription drug plan sponsors and Medicare Advantage (MA) organizations, etc. Comments on issues related to actuarial equivalence in a separate letter. (October 4, 2004)